Literature DB >> 1537134

Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening.

F G St Goar1, F J Pinto, E L Alderman, H A Valantine, J S Schroeder, S Z Gao, E B Stinson, R L Popp.   

Abstract

BACKGROUND: Accelerated coronary atherosclerosis is a major factor limiting allograft longevity in cardiac transplant recipients. Histopathology studies have demonstrated the insensitivity of coronary angiography for detecting early atheromatous disease in this patient population. Intracoronary ultrasound is a new imaging technique that provides characterization of vessel wall morphology. The purpose of this study was to compare in vivo intracoronary ultrasound with angiography in cardiac transplant recipients. METHODS AND
RESULTS: The left anterior descending coronary artery was studied with intracoronary ultrasound in 80 cardiac transplant recipients at the time of routine screening coronary angiography 2 weeks to 13 years after transplantation. A mean and index of intimal thickening were obtained at four coronary sites. Intimal proliferation was classified as minimal, mild, moderate, or severe according to thickness and degree of vessel circumference involved. Twenty patients were studied within 1 month of transplantation and had no angiographic evidence of coronary disease. An intimal layer was visualized by ultrasound in only 13 of these 20 presumably normal hearts. The 60 patients studied 1 year or more after transplantation all had at least minimal intimal thickening. Twenty-one patients (35%) showed minimal or mild, 17 (28%) moderate, and 21 (35%) severe thickening. Forty-two of these 60 patients had angiographically normal coronary arteries, 21 (50%) of whom had either moderate or severe thickening. All 18 patients with angiographic evidence of coronary disease had moderate or severe intimal thickening, but there was no statistically significant difference in intimal thickness or index when compared with the patients with moderate or severe proliferation and normal angiograms (thickness, 0.53 +/- 0.35 mm versus 0.64 +/- 0.30 mm, p = NS; index, 0.28 +/- 0.10 versus 0.34 +/- 0.10, p = NS).
CONCLUSIONS: The majority of patients 1 or more years after cardiac transplantation have ultrasound evidence of intimal thickening not apparent by angiography. Intracoronary ultrasound offers early detection and quantitation of transplant coronary disease and provides characterization of vessel wall morphology, which may prove to be a prognostic marker of disease.

Entities:  

Mesh:

Year:  1992        PMID: 1537134     DOI: 10.1161/01.cir.85.3.979

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  45 in total

Review 1.  Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis.

Authors:  Gregory A Payne; Fadi G Hage; Deepak Acharya
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

Review 2.  Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: current practice and future directions.

Authors:  Clifford Chin; Daniel Bernstein
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Changes in coronary anatomy and physiology after heart transplantation.

Authors:  Atsushi Hirohata; Mamoo Nakamura; Katsuhisa Waseda; Yasuhiro Honda; David P Lee; Randall H Vagelos; Sharon A Hunt; Hannah A Valantine; Paul G Yock; Peter J Fitzgerald; Alan C Yeung; William F Fearon
Journal:  Am J Cardiol       Date:  2007-04-19       Impact factor: 2.778

4.  Elevated serum vascular endothelial growth factor and development of cardiac allograft vasculopathy in children.

Authors:  Kae Watanabe; Anis Karimpour-Fard; Alix Michael; Shelley D Miyamoto; Stephanie J Nakano
Journal:  J Heart Lung Transplant       Date:  2018-04-30       Impact factor: 10.247

5.  Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.

Authors:  Travis B DeSa; Muhannad A Abbasi; Julie A Blaisdell; Kai Lin; Jeremy D Collins; James C Carr; Michael Markl
Journal:  Clin Imaging       Date:  2019-12-19       Impact factor: 1.605

6.  Dual-source CT coronary imaging in heart transplant recipients: image quality and optimal reconstruction interval.

Authors:  Gorka Bastarrika; Carlo N De Cecco; Maria Arraiza; Matias Ubilla; Stefano Mastrobuoni; Jesús C Pueyo; Gregorio Rábago
Journal:  Eur Radiol       Date:  2008-04-17       Impact factor: 5.315

7.  Surveillance cardiac catheterisation in heart transplant recipients.

Authors:  C B Kim; A C Yeung
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

8.  Dual-source cardiac computed tomography angiography (CCTA) in the follow-up of cardiac transplant: comparison of image quality and radiation dose using three different imaging protocols.

Authors:  D Beitzke; V Berger-Kulemann; V Schöpf; S Unterhumer; E Spitzer; G M Feuchtner; M Gyöngyösi; K Uyanik-Uenal; A Zuckermann; C Loewe; F Wolf
Journal:  Eur Radiol       Date:  2015-04-26       Impact factor: 5.315

9.  Safety of regadenoson positron emission tomography stress testing in orthotopic heart transplant patients.

Authors:  John J Lazarus; Ashraf Saleh; Michael Ghannam; Keith Aaronson; Monica Colvin; Frank Pagani; Todd Koelling; James R Corbett; Richard L Weinberg; Venkatesh L Murthy; Matthew C Konerman
Journal:  J Nucl Cardiol       Date:  2018-11-27       Impact factor: 5.952

Review 10.  New developments in the diagnosis and management of cardiac allograft vasculopathy.

Authors:  M R Mehra; H O Ventura; F W Smart; D D Stapleton; T J Collins; S R Ramee; J P Murgo; C J White
Journal:  Tex Heart Inst J       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.